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Abstract
Background: Midgut carcinoids are neuroendocrine tumors that commonly metastasize to the intestinal
mesentery, where they predispose to intestinal obstruction, ischemia and/or congestion. Because of their location,
many mesenteric carcinoid tumors are deemed unresectable due to the risk of uncontrollable bleeding and
prolonged intestinal ischemia.
Case Presentation: We report the case of a 60-year-old male with a mesenteric carcinoid tumor obstructing his
superior mesenteric vein, resulting in intestinal varices and severe recurrent GI bleeds. While his tumor was thought
to be unresectable by conventional techniques, it was successfully resected using intestinal autotransplantation to
safely gain access to the tumor. This case is the first described application of this technique to carcinoid tumors.
Conclusions: Intestinal autotransplantation can be utilized to safely resect mesenteric carcinoid tumors from
patients who were not previously thought to be surgical candidates. We review the literature concerning both
carcinoid metastases to the intestinal mesentery and the use of intestinal autotransplantation to treat lesions
involving the mesenteric root.
Background
Carcinoid tumors are the most common neuroendocrine
neoplasm, typically arising in the respiratory and midgut
gastrointestinal tracts [1,2]. While midgut carcinoid
tumors are usually slow growing, they are often asso-
ciated with severe complications from early metastasis to
the liver and the small bowel mesentery [3]. These
mesenteric carcinoid tumors release serotonin and other
growth factors which induce a desmoplastic reaction
causing diffuse mesenteric fibrosis and encasement of cri-
tical mesenteric vasculature, which in turn predisposes to
intestinal obstruction, hypoperfusion and/or congestion
[4]. Several groups have published surgical strategies for
debulking mesenteric carcinoid disease [5-7]. However,
complete encasement of the mesenteric vasculature has
traditionally been considered an absolute contraindica-
tion to surgery given the risk of uncontrollable bleeding
or inducing prolonged intestinal ischemia [3]. Here we
describe a novel technique to resect extensive mesenteric
root carcinoid metastases using partial abdominal evis-
ceration and intestinal autotransplantation.
Case presentation
A 60-year-old man presented to our unit in January
2008 with a mesenteric carcinoid tumor compressing
the superior mesenteric vein, resulting in recurrent epi-
sodes of GI bleeding from mesenteric varices. His rele-
vant medical history began in 2005, when he underwent
a work-up at another institution for chronic diarrhea at
that time. He complained of up to 15 watery bowel
movements a day for the past several years. He under-
went an unrevealing esophagogastroduodenoscopy
(EGD) and colonoscopy, but an abdominal CT scan
showed a 4.6 × 2.5 cm mesenteric soft tissue mass
encasing the superior mesenteric vein and extending
along the mesenteric root to the base of the pancreas
(Figure 1). Multiple mesenteric varices were noted on
this original CT scan, and several small bowel loops
appeared thickened with probable venous congestion.
Both 24-hour urine 5-HIAA (14.7 mg, normal 2-6 mg)
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ng/mL) were elevated, consistent with a diagnosis of
mesenteric carcinoid tumor. His tumor was deemed
inoperable after the outside institution’s evaluation, and
he was referred to a medical oncologist at our hospital.
Additional studies then included an EGD with endo-
scopic ultrasound (EUS) and a fine needle-aspiration
biopsy of the mass. These showed a 3.5 cm mass encas-
ing the SMV, and the biopsy confirmed that he had a
chromogranin-positive, synaptophysin-positive, keratin
AE1/AE3-positive, NSE-negative well-differentiated car-
cinoid tumor without evidence of atypia (no mitoses or
necrosis, ENETS grade G1). Mesenteric angiography
revealed severe stenosis or occlusion of multiple SMA
branches such as the ileocolic artery, which was recon-
stituted distally by jejunoileal collaterals (Figure 2).
Staging chest/abdomen/pelvis CT scans showed no evi-
dence of metastatic disease. He was offered participation
in a clinical trial but declined, choosing instead to
receive standard therapy with octreotide long-acting
release (LAR).
His disease remained fairly stable for almost two years
on octreotide, with only slight progressive enlargement
of his mesenteric mass on interval abdominal CT scans.
Starting in August 2007, however, he required multiple
hospital admissions for GI bleeding. Colonoscopy was
unremarkable, and an EGD showed thickened folds in
the second portion of the duodenum. A video-capsule
endoscopy revealed diffuse congested mucosa through-
out the jejunum, with a few localized erosions. A push
enteroscopy was performed, but his duodenal and jejunal
varices were not amenable to intervention. By January
2008, he was requiring 2-4 units of red blood cell trans-
fusions a week due to continued GI bleeding; a pallia-
tive care consult was obtained and preparations were
made to proceed with home hospice. At this point he
was referred for a second surgical opinion. Given his
otherwise state of good health and his desire for aggres-
sive treatment of his carcinoid tumor, it was determined
that we should attempt a palliative resection including
partial abdominal evisceration for resection of his
mesenteric carcinoid tumor and reconstruction via
intestinal autotransplantation.
Operative technique
Laparotomy was performed through a bilateral subcostal
incision. The carcinoid tumor was confirmed to involve
the root of the small bowel mesentery, extending down
Figure 1 Preoperative abdominal CT scan demonstrating large
mesenteric soft tissue mass (white arrows) encasing the
mesenteric vasculature with evident bowel wall and
mesenteric edema, along with trace ascites fluid.
Figure 2 Pre-operative mesenteric angiogram.W h e r e a st h e
celiac and inferior mesenteric arteries were patent, cannulation of
the superior mesenteric artery shown here reveals severe stenosis or
occlusion of multiple SMA branches (black arrows) from extrinsic
compression by the carcinoid tumor. Flow to the ileocolic artery is
occluded proximally and reconstituted distally from jejunoileal
collaterals.
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nopathy of the para-aortic nodes. There was no evidence
of hepatic metastasis, but the duodenum and head of
the pancreas were involved. The mesentery of the ileum
and jejunum was investigated to find suitable vessels for
anastomosis. The tumor extended past the confluence
of the ileocolic artery with the first jejunal artery branch,
therefore requiring that the intestine be autotrans-
planted in two separate segments. The distal ileocolic
artery was deemed suitable to support the cecum and
terminal ileum, and the jejunal artery was selected to
support a large segment of jejunum and proximal ileum.
The Kocher maneuver was performed, followed by a
radical lymphadenectomy along the vena cava and aorta.
A pre-pyloric division of the stomach was made, and
the jejunum was divided just distal to the ligament of
Treitz. The common hepatic bile duct was divided dis-
tally and the pancreaticoduodenectomy was completed
by dividing the neck of the pancreas. At this time, both
the ileocecal and ileojejunal segments of bowel were
removed and transported to the back table, where they
were each flushed with 2 L of UW preservation solution
and kept on ice. The resection continued by transecting
the superior mesenteric artery, leaving a stump of about
2 cm behind. The portal vein was dissected free and
then the superior mesenteric vein was divided 2 cm
proximal to its confluence with the splenic vein. The
descending colon was stapled off just distal to the sple-
nic flexure. The resected specimen included the mesen-
teric root, pancreatic head, duodenum and ascending/
transverse colon. The ileojejunal segment of intestine
was then brought back to the field and was revascular-
ized via the retained superior mesenteric artery stump
and the transsected distal superior mesenteric vein.
The bowel reperfused well. Next, the infrarenal vena
cava and the aorta below the take-off of the inferior
mesenteric artery were utilized to complete end-to-side
vascular anastomosis for the ileocolic segment of
bowel. This bowel segment also reperfused well. GI
tract continuity was completed using a pancreaticojeju-
nostomy, gastrojejunostomy and choledochojejunost-
omy and an end-to-end ileoileostomy to connect the
two segments of autotransplanted bowel. The descend-
ing colon was left stapled off, and a Bardex cecostomy
tube was brought out through the skin to temporarily
drain the cecum (Figure 3A). The abdomen was irri-
gated and closed in layers.
Post-operative course
Final pathology revealed well-differentiated multifocal
carcinoid of the small bowel with metastases to the
mesentery (where a 6.5 cm mass was identified) and
mesenteric lymph nodes (9 of 18 nodes positive). All
resection margins were negative for malignancy. By
TNM staging (as defined by ENETS), his tumor was
stage IIIB. The patient had a complicated post-operative
course. A second-look laparotomy performed on post-
operative day 1 revealed all of the bowel to be viable.
The patient was brought back to the operating room on
postoperative day 4 with plans to connect the cecum
and descending colon. At this laparotomy, the ileojeju-
nal segment of bowel looked dusky, albeit not frankly
necrotic. The ileocolic segment remained pink and well-
perfused. A near-occlusive clot was found at the super-
ior mesenteric artery anastomosis. Fogarty thrombect-
omy restored good flow to that bowel segment.
Continued acidosis and hemodynamic instability
required re-exploration the next day, at which point a
large thrombus was again palpated in the SMA, and the
ileojejunal segment of bowel was found to be nonviable.
This segment of transplanted bowel was therefore
resected, requiring take-down of the pancreaticojeju-
nostomy, choledochojejunostomy and gastrojejunost-
omy. Reconstruction could not be performed with the
ileocecal segment of bowel in its current location, so
this segment was explanted, flushed with ice-cold lac-
tated Ringer solution containing mannitol and then kept
on ice. The venotomy and arteriotomy on the vena cava
and abdominal aorta were patched with pieces of ileal
Figure 3 A. Initial postoperative anatomy. Both ileocecal and
ileojejunal segments of bowel were removed to permit access and
resection of the mesenteric carcinoid tumor. The ileojejunal
autograft was revascularized by anastomosing the jejunal artery and
vein to the residual stumps of the SMA and SMV. The ileocecal
segment was revascularized by anastomosing the ileocolic vessels
to the abdominal aorta and IVC. The GI tract was reconstructed with
a pancreaticojejunostomy, hepaticojejunostomy, gastrojejunostomy
and ileoileostomy. B. Final postoperative anatomy. Due to SMA
thrombosis, the jejunoileal bowel autograft was lost. The ileocolic
segment was explanted and revascularized using the SMA and SMV
stumps. GI tract continuity was restored with a
pancreaticoileostomy, hepaticoileostomy, gastroileostomy and
cecocolostomy.
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(including ~70 cm of ileum) was then revascularized via
the superior mesenteric artery and vein. The bowel was
pink immediately upon reperfusion. A pancreaticoileost-
omy, gastroileostomy and choledochoileostomy were
then performed in the standard fashion. Reconstruction
was completed by anastomosing the cecum to the des-
cending colon (Figure 3B). Postoperatively, he was
started on a heparin drip to prevent further thrombosis
and he was successfully extubated the next day.
His subsequent hospital course was remarkable for
periodic febrile episodes requiring first IR drain place-
ment into a pelvic fluid collection (which grew Candida
albicans) and a final laparotomy for abdominal washout
with saline containing amphotericin B and gentamicin.
He did have a small leak at his pancreaticoileostomy
that was managed conservatively with NPO status and
initiation of TPN. He was discharged on TPN on POD
72, tolerating some tube feeds and enteral intake.
Outcome
Over the ensuing months the patient required several
short hospitalizations for central venous line infections
related to his TPN, in addition to endocarditis. He was
ultimately weaned off parenteral nutrition and his
weight has stabilized. He had recovered well enough to
undergo an aortic valve replacement in December 2009.
Currently, 2.5 years after his carcinoid resection, he is
completely independent of parenteral nutrition or tube
feeds. He continues to have mild diarrhea, well-
controlled with cholestyramine. Surveillance abdominal
CT scans reveal no evidence of carcinoid recurrence or
metastasis, and his chromogranin A in March 2010 was
within normal limits (93 ng/ml, reference < 225 ng/ml).
Discussion
Of the gastrointestinal carcinoids, those arising from the
midgut (e.g. small intestine and appendix) are by far the
most common, with tumors distal to the jejunum repre-
senting 96% of carcinoids located in the gastrointestinal
tract [8]. These midgut carcinoids secrete serotonin and
are responsible for the carcinoid syndrome, the intract-
able flushing and diarrhea associated with metastasis to
the liver. In addition to hepatic metastasis, midgut carci-
noids also commonly metastasize to the small bowel
mesentery [3]. Indeed, radiographic studies indicate
mesenteric involvement in 40-80% of patients with
abdominal carcinoid tumors [9-11].
Carcinoid metastases to the mesentery often grow far
larger than the submucosal primary tumors in the small
bowel wall, and they are responsible for much of the
morbidity and mortality of gastrointestinal carcinoid
tumor that is not attributable to carcinoid syndrome
itself. Many patients with mesenteric carcinoid present
with small bowel obstructive symptoms due to tethering
and kinking of the small bowel to the rigid mesentery.
In several surgical case series of patients with midgut
carcinoids, 62-67% required laparotomy for either intest-
inal obstruction or abdominal pain, and of these
patients, 67-79% had evidence of extensive mesenteric
fibrosis upon surgical exploration [12,13]. In other cases,
the mesenteric vasculature (e.g. superior mesenteric
artery and vein) can become completely encased in
tumor, causing regional portal hypertension and arterial
insufficiency [14-16]. The encasement of the visceral
vasculature may manifest as episodes of post-prandial
acute abdominal pain or as GI bleeds (noted in 5% of
midgut carcinoid patients in one case series) [3,13].
Although somatostatin analogs such as octreotide
remain the mainstay of carcinoid therapy, surgical resec-
tion has emerged as a vital treatment in disease manage-
ment. For metastatic disease, palliative cytoreductive
surgery has been employed by some groups to specifi-
cally address mesenteric carcinoids. While some symp-
tomatic improvement is often reported, long-term
outcomes are compromised by recurrent disease
[5,17,18]. Unfortunately, large mesenteric carcinoids
h a v eo f t e nb e e nc o n s i d e r e du nresectable due to their
position abutting critical vascular structures in the
abdomen.
Recently, however, several groups have published
reports outlining the use of intestinal autotransplanta-
tion to safely gain access and resect tumors that encase
the vasculature of the mesenteric root. Utilizing techni-
ques from intestinal allotransplantation, the patient’s
small intestine is harvested en bloc a n dm a i n t a i n e di n
cold preservative fluid to limit warm ischemia injury.
The mesenteric mass is then fully excised, and the intes-
tine is autotransplanted back into the patient. This strat-
egy was first employed by David Lai and colleagues to
treat a nonfunctioning islet cell carcinoma [19]. That
patient also underwent a total pancreatectomy, gastrect-
omy, splenectomy and hepatic revascularization (as his
proximal hepatic artery was also resected). Vascular ana-
stomoses were performed between the hepatic artery
and aorta, distal superior mesenteric artery and aorta,
and between the distal superior mesenteric vein and
cephalad portal vein.
A similar approach was employed by Tzakis and col-
leagues to treat four patients with lesions involving the
root of the mesentery. The indications for resection in
these patients were pancreatic head fibroma, vascular
malformation at the mesenteric root, desmoid tumor of
the pancreatic tail, and locally advanced pancreatic ade-
nocarcinoma [20,21]. Whereas we employed in situ
resection of the carcinoid tumor, the patients in Tzakis’
case series had ex vivo resection of their lesions on ice
on the back table after their organs had been removed
Kitchens et al. World Journal of Surgical Oncology 2011, 9:11
http://www.wjso.com/content/9/1/11
Page 4 of 6en bloc. The mesenteric lesions of his series did not
apparently extend into the distal branches of the SMA,
obviating the need to autotransplant multiple segments
of intestine as in the case we present here. All of his
patients had good outcomes except for the patient trea-
ted for pancreatic cancer, who died of hepatic metas-
tases 7 months postoperatively. Two additional case
reports of intestinal autotransplantation to treat locally-
advanced pancreatic cancer extending into the mesen-
teric root were also complicated by rapid recurrence of
hepatic or peritoneal metastases, and early death after
the procedure [22,23]. These reports cast doubt on
whether this aggressive surgical strategy is warranted for
cases of pancreatic cancer.
Conclusion
Here we present the first description of partial abdom-
inal evisceration and intestinal autotransplantation used
to treat a mesenteric carcinoid tumor. This method may
prove particularly useful for midgut carcinoid tumors, as
this malignancy frequently extends into the mesenteric
root, with enormous clinical consequences. While stent-
ing of the superior mesenteric vein was recently
described to palliate the symptoms of intestinal conges-
tion that often accompany mesenteric spread of midgut
carcinoids [24], intestinal autotransplantation permits
tumor resection with possible curative results. In con-
junction with earlier studies, this report demonstrates
that intestinal autotransplantation is a surgical strategy
that can be used to successfully treat a variety of lesions
involving the mesenteric root, including many that were
previously thought to be unresectable.
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